BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 6006070)

  • 1. Studies on sulfone resistance in leprosy. 2. Treatment with a riminophenazine derivative (B.663).
    Pettit JH; Rees RJ
    Int J Lepr Other Mycobact Dis; 1966; 34(4):391-7. PubMed ID: 6006070
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemotherapeutic trials in leprosy. 3. Pilot trial of a riminophenazine derivative. B.663, in the treatment of lepromatous leprosy.
    Pettit JH; Rees RJ; Ridley DS
    Int J Lepr Other Mycobact Dis; 1967; 35(1):25-33. PubMed ID: 5336368
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on sulfone resistance in leprosy. I. Detection of cases.
    Pettit JH; Rees RJ; Ridley DS
    Int J Lepr Other Mycobact Dis; 1966; 34(4):375-90. PubMed ID: 6006069
    [No Abstract]   [Full Text] [Related]  

  • 4. The treatment of leprosy with the sulfones. I. Faget's original 22 patients. A thirty-year follow-up on sulfone therapy for leprosy.
    Jacobson RR; Trautman JR
    Int J Lepr Other Mycobact Dis; 1971; 39(3):726-37. PubMed ID: 4948221
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on sulfone resistance in leprosy. 3. A case of "partial" resistance.
    Pearson JM; Pettit JH; Rees RJ
    Int J Lepr Other Mycobact Dis; 1968; 36(2):171-8. PubMed ID: 4877115
    [No Abstract]   [Full Text] [Related]  

  • 6. Sulfone resistance and leprosy control.
    Lechat MF
    Int J Lepr Other Mycobact Dis; 1978; 46(1):65-7. PubMed ID: 565757
    [No Abstract]   [Full Text] [Related]  

  • 7. G 30 320 or B 663--lampren (Geigy).
    Waters MF
    Lepr Rev; 1969 Jan; 40(1):21-47. PubMed ID: 4888382
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemotherapeutic trials in leprosy. 6. Pilot study of the riminophenazine derivative B.663 in low dosage (100 mgm. twice weekly) in the treatment of lepromatous leprosy.
    Waters MF
    Int J Lepr Other Mycobact Dis; 1968; 36(4):391-9. PubMed ID: 4898403
    [No Abstract]   [Full Text] [Related]  

  • 9. B.663 and erythema nodosum leprosum.
    Pettit JH
    Int J Lepr Other Mycobact Dis; 1967; 35(3):401-2. PubMed ID: 5630363
    [No Abstract]   [Full Text] [Related]  

  • 10. The treatment of erythema nodosum leprosum with B.663. A controlled study.
    Pettit JH
    Int J Lepr Other Mycobact Dis; 1967; 35(1):11-6. PubMed ID: 4290017
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of sulphone resistant leprosy--a review of sixty one cases.
    Seshadri PS; Ravi NT
    Lepr India; 1982 Oct; 54(4):639-47. PubMed ID: 6191123
    [No Abstract]   [Full Text] [Related]  

  • 12. Erythema nodosum leprosum.
    Fowler PD
    Int J Lepr Other Mycobact Dis; 1967; 35(3):397-8. PubMed ID: 4318423
    [No Abstract]   [Full Text] [Related]  

  • 13. [. 663 (G 30320 "Geigy"), a new chemotherapeutic agent against leprosy].
    Vischer WA
    Schweiz Med Wochenschr; 1967 Mar; 97(10):308. PubMed ID: 5585384
    [No Abstract]   [Full Text] [Related]  

  • 14. [Early diagnosis, therapy, and research in the control of leprosy].
    Contreras Duenas F
    Offentl Gesundheitswes; 1970 Dec; 32(12):667-71. PubMed ID: 4250373
    [No Abstract]   [Full Text] [Related]  

  • 15. Erythema nodosum leprosum.
    Pettit JH
    Int J Lepr Other Mycobact Dis; 1967; 35(3):400-1. PubMed ID: 4318424
    [No Abstract]   [Full Text] [Related]  

  • 16. A survey of the drugs with activity against M. leprae in mice.
    Shepard CC
    Int J Lepr Other Mycobact Dis; 1971; 39(2):340-8. PubMed ID: 4948080
    [No Abstract]   [Full Text] [Related]  

  • 17. B.663 (Geigy 30. 320) in the treatment of leprosy. A preliminary report.
    Devadason C
    Acta Trop; 1969; 26(3):265-9. PubMed ID: 4391239
    [No Abstract]   [Full Text] [Related]  

  • 18. Leprosy research at the National Institutes of Health: experience with B.663 in the treatment of leprosy.
    Williams TW; Mott PD; Wertlake PT; Rubio JB; Adler RC; Hill GJ; Suarez GP; Knight V
    Int J Lepr; 1965; 33(3):Suppl:767-77. PubMed ID: 5322715
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of leprosy with Lampren (B.663 Geigy).
    De las Aguas JT
    Int J Lepr Other Mycobact Dis; 1971; 39(2):493-503. PubMed ID: 4948089
    [No Abstract]   [Full Text] [Related]  

  • 20. Further studies on B.663 in murine leprosy. Absence of resistance of M. lepraemurium to B.663 and delay in development of resistance to isoniazid.
    Chang YT
    Int J Lepr Other Mycobact Dis; 1966; 34(1):1-6. PubMed ID: 5327050
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.